Skip to main content

Galante Joseph C's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Dec 23, 2022

Accession no.
0001209191-22-062643
Filed
Dec 23, 2022
Trade date
Nov 1-30, 2022
Filing delay
52 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions and 0 derivative transactions. Open-market purchases total $3.24K. It was filed 52 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Galante Joseph CCIK 0001632384Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 1, 2022Common StockPPurchaseAcquired+65$2.53+$164.4554,506Direct
Nov 2, 2022Common StockPPurchaseAcquired+65$2.54+$165.154,571Direct
Nov 3, 2022Common StockPPurchaseAcquired+65$2.44+$158.654,636Direct
Nov 4, 2022Common StockPPurchaseAcquired+65$2.42+$157.354,701Direct
Nov 7, 2022Common StockPPurchaseAcquired+65$2.45+$159.2554,766Direct
Nov 8, 2022Common StockPPurchaseAcquired+65$2.42+$157.354,831Direct
Nov 9, 2022Common StockPPurchaseAcquired+65$2.37+$154.0554,896Direct
Nov 10, 2022Common StockPPurchaseAcquired+65$2.37+$154.0554,961Direct
Nov 11, 2022Common StockPPurchaseAcquired+65$2.32+$150.855,026Direct
Nov 14, 2022Common StockPPurchaseAcquired+65$2.32+$150.855,091Direct
Nov 15, 2022Common StockPPurchaseAcquired+65$2.35+$152.7555,156Direct
Nov 16, 2022Common StockPPurchaseAcquired+65$2.31+$150.1555,221Direct
Nov 17, 2022Common StockPPurchaseAcquired+65$2.29+$148.8555,286Direct
Nov 18, 2022Common StockPPurchaseAcquired+65$2.27+$147.5555,351Direct
Nov 21, 2022Common StockPPurchaseAcquired+65$2.38+$154.755,416Direct
Nov 22, 2022Common StockPPurchaseAcquired+65$2.37+$154.0555,481Direct
Nov 23, 2022Common StockPPurchaseAcquired+65$2.29+$148.8555,546Direct
Nov 25, 2022Common StockPPurchaseAcquired+65$2.31+$150.1555,611Direct
Nov 28, 2022Common StockPPurchaseAcquired+65$2.37+$154.0555,676Direct
Nov 29, 2022Common StockPPurchaseAcquired+65$2.34+$152.155,741Direct
Nov 30, 2022Common StockPPurchaseAcquired+65$2.32+$150.855,806Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)